Novo Nordisk shares rebound as FDA targets illegal drug copies
By Jacob Gronholt-Pedersen COPENHAGEN, Feb 6 (Reuters) – Shares in Danish drugmaker Novo Nordisk gained 5.4% on Friday,…
FDA targets illegal drug copies amid latest Hims & Hers/Novo Nordisk flashpoint
US Food and Drug Administration (FDA) Commissioner Marty Makary said the agency would target the mass-marketing of unapproved…